Dr. Ula Jurkunas, MD
Claim this profileMassachusetts Eye and Ear Infirmary
Studies Corneal Dystrophy
Studies Fuchs Endothelial Corneal Dystrophy
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Ula Jurkunas, MD is currently running
NAC Eye Drops
for Fuchs' Dystrophy
This trial tests if NAC eye drops can protect eye cells by reducing harmful oxidative stress in patients with advanced FECD and cataracts. The study involves patients who are already scheduled for eye surgeries. NAC is expected to help by protecting the corneal cells from damage. NAC has been used topically in the treatment of various eye conditions due to its antioxidant, anti-inflammatory, and mucolytic properties.
Recruiting1 award Phase 26 criteria
Contact Lens Wear
for Fuchs' Dystrophy
The purpose of this study is to determine the difference in the cornea's response to contact lens placement between healthy and unhealthy eyes. The amount of corneal swelling (corneal thickness) between normal and FECD patients before and after a stress test will be measured and compared.
Recruiting1 award Phase 1 & 26 criteria
More about Ula Jurkunas, MD
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ula Jurkunas, MD has experience with
- Wearing Of Contact Lens
- N-acetyl Cysteine (NAC) 10% Solution
- N-acetyl Cysteine (NAC) 20% Solution
- Visine Dry Eye Relief Eye Drops
- CALEC Graft
Breakdown of trials Ula Jurkunas, MD has run
Fuchs Endothelial Corneal Dystrophy
Limbal Stem Cell Deficiency
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ula Jurkunas, MD specialize in?
Ula Jurkunas, MD focuses on Corneal Dystrophy and Fuchs Endothelial Corneal Dystrophy. In particular, much of their work with Corneal Dystrophy has involved Stage IV patients, or patients who are undergoing treatment.
Is Ula Jurkunas, MD currently recruiting for clinical trials?
Yes, Ula Jurkunas, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Ula Jurkunas, MD has studied deeply?
Yes, Ula Jurkunas, MD has studied treatments such as Wearing of contact lens, N-acetyl cysteine (NAC) 10% solution, N-acetyl cysteine (NAC) 20% solution.
What is the best way to schedule an appointment with Ula Jurkunas, MD?
Apply for one of the trials that Ula Jurkunas, MD is conducting.
What is the office address of Ula Jurkunas, MD?
The office of Ula Jurkunas, MD is located at: Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts Eye and Ear Infirmary.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.